Pharmacodynamic Evaluation of Intranasal Nalmefene
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is to determine the pharmacodynamics (the effects of the drug and mechanisms of
their action within the body) of Nalmefene when given intranasally (IN; into the nose)
compared to intranasal naloxone when given to healthy volunteers under steady state opioid
agonism.